Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 58
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Scand J Gastroenterol ; 53(10-11): 1404-1410, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30343606

RESUMEN

OBJECTIVES: Heat shock protein (HSP) 70 performs a chaperoning function and protects cells against injury. Although the effect of HSPs against acute inflammatory change has been proven, the relationship between HSP70 and chronic pancreatitis remains unclear. This study aimed to investigate the protective effect of increased HSP70 expression induced by thermal stress against pancreatic fibrosis in experimental chronic pancreatitis. MATERIALS AND METHODS: Two experiments to evaluate pancreatic HSP70 expression induced by thermal stress and determine the effect of increased HSP70 expression against pancreatic fibrosis were performed. To investigate HSP70 expression, rats were immersed in a warm bath and sequentially killed, and pancreatic HSP70 expression was measured. To study the effect of increased HSP70 expression, pancreatic fibrosis was induced by intravenous injection of dibutyltin dichloride (DBTC) and analyzed under repeated thermal stress. The severity of pancreatic fibrosis was measured. RESULTS: Thermal stress significantly increased HSP70 expression in the pancreas. HSP70 expression peaked at 6-12 h after warm bathing, and the increased HSP70 expression was associated with the attenuation of pancreatic fibrosis. Although pancreatic fibrosis was induced by DBTC injection, HSP70 expression induced by repeated thermal stress diminished the severity of atrophy and fibrosis. On western blot analysis, collagen type 1 expression was diminished in the increased HSP70 expression group, but not α-smooth muscle actin expression. CONCLUSIONS: Thermal stress could increase pancreatic HSP70 expression, and induced HSP70 expression showed a protective effect against pancreatic fibrosis. Modulation of HSP70 expression could be a potential therapeutic target in the treatment of chronic pancreatitis.


Asunto(s)
Colágeno Tipo I/metabolismo , Proteínas HSP70 de Choque Térmico/metabolismo , Páncreas/patología , Pancreatitis Crónica/patología , Animales , Western Blotting , Fibrosis/prevención & control , Hipertermia Inducida , Masculino , Compuestos Orgánicos de Estaño/administración & dosificación , Pancreatitis Crónica/inducido químicamente , Ratas , Ratas Sprague-Dawley
2.
J Toxicol Sci ; 42(6): 741-753, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29142173

RESUMEN

In order to elucidate the effect of chorioallantoic and yolk sac placenta on the embryonic/fetal toxicity in dibutyltin dichloride (DBTCl)-exposed rats, we examined the histopathological changes and the tissue distribution of dibutyltin in the placentas and embryos. DBTCl was orally administered to the groups at doses of 0 mg/kg during gestation days (GD)s 7-9 (control group) and 20 mg/kg during GDs 7-9 (GD7-9 treated group), and GDs 10-12 (GD10-12 treated group). The total fetal mortality was increased, and malformations characterized by craniofacial dysmorphism were detected in the GD7-9 treated group. The embryonic/fetal weight and placental weight showed a decrease in both DBTCl-treated groups. Histologically, some embryos on GD 9.5 in the GD7-9 treated group underwent apoptosis without any changes of yolk sac. In the laser ablation-inductively coupled plasma-mass spectrometry analysis (LA-ICP-MS), tin was detected in the embryo, allantois, yolk sac, ectoplacental cone and decidual mass surrounding the conceptus on GD 9.5 in the GD7-9 treated group. Thus, it is considered that the embryo in this period is specifically sensitive to DBTCl-induced apoptosis, compared with other parts. The chorioallantoic placentas in both DBTCl-treated groups showed the developmental delay and hypoplasia in the fetal parts of placenta, resulting from apoptosis and mitotic inhibition. Thus, it was speculated that the DBTCl-induced malformations and fetal resorption resulted from the apoptosis in the embryo caused by the direct effect of DBTCl. The DBTCl-induced lesions in the chorioallantoic placenta were a non-specific transient developmental retardation in the fetal parts of placenta, leading to intrauterine growth retardation.


Asunto(s)
Retardo del Crecimiento Fetal/inducido químicamente , Intercambio Materno-Fetal/efectos de los fármacos , Compuestos Orgánicos de Estaño/toxicidad , Placenta/efectos de los fármacos , Administración Oral , Animales , Apoptosis/efectos de los fármacos , Huesos Faciales/anomalías , Huesos Faciales/embriología , Femenino , Mortalidad Fetal , Peso Fetal/efectos de los fármacos , Edad Gestacional , Masculino , Tamaño de los Órganos/efectos de los fármacos , Compuestos Orgánicos de Estaño/administración & dosificación , Compuestos Orgánicos de Estaño/farmacocinética , Placenta/anatomía & histología , Placenta/metabolismo , Embarazo , Ratas Wistar , Cráneo/anomalías , Cráneo/embriología , Distribución Tisular
3.
Gen Physiol Biophys ; 36(4): 481-484, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28836501

RESUMEN

In the present study, we analyzed in vitro effects of natural and synthetic triorganotin ligands of nuclear retinoid X receptors in human MCF-7 breast cancer cells. Our data has shown that all-trans retinoic acid significantly reduced expression of RXRalpha mRNA, Bcl2 and enhanced expression of BAX proteins. Tributyltin bromide markedly decreased mRNA level of RXRalpha and RXRbeta. Significantly reduced levels of both RXRs proteins were observed after treatment with tributyltin chloride (TBT-Cl) but not after treatment with triphenyltin chloride (TPT-Cl) for RXRbeta protein. Both RXRalpha and RXRbeta protein levels decrease was found also by combination ATRA+TBT-Cl/TPT-Cl.


Asunto(s)
Núcleo Celular/metabolismo , Compuestos Orgánicos de Estaño/administración & dosificación , Receptores X Retinoide/metabolismo , Tretinoina/administración & dosificación , Núcleo Celular/efectos de los fármacos , Humanos , Células MCF-7
4.
Dalton Trans ; 45(47): 18984-18993, 2016 Dec 21.
Artículo en Inglés | MEDLINE | ID: mdl-27847952

RESUMEN

SBA-15|Sn3, a mesoporous silica-based material (derivative of SBA-15) loaded with an organotin compound Ph3Sn(CH2)3OH (Sn3), possesses improved antitumor potential against the A2780 high-grade serous ovarian carcinoma cell line in comparison to Sn3. It is demonstrated that both the compound and the nanostructured material are internalized by the A2780 cells. A similar mode of action of Sn3 and SBA-15|Sn3 against the A2780 cell line was found. Explicitly, induction of apoptosis, caspase 2, 3, 8 and 9 activation, accumulation of cells in the hypodiploid phase as well as accumulation of ROS were observed. Interestingly, Sn3 loaded in the mesoporous silica-based material needed to reach a concentration 3.5 times lower than the IC50 value of the Sn3 compound, pointing out a higher effect of the SBA-15|Sn3 than Sn3 alone. Clonogenic potential, growth in 3D culture as well as mobility of cells were disturbed in the presence of SBA-15|Sn3. Such behavior could be associated with the suppression of p-38 MAPK. Less profound effect of Sn3 compared to SBA-15|Sn3 could be attributed to a different regulation of p-38 and STAT-3, which are mainly responsible for an appropriate cellular response to diverse stimuli or metastatic properties.


Asunto(s)
Antineoplásicos/administración & dosificación , Portadores de Fármacos/administración & dosificación , Compuestos Orgánicos de Estaño/administración & dosificación , Dióxido de Silicio/administración & dosificación , Antineoplásicos/química , Antineoplásicos/farmacología , Caspasas/metabolismo , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Portadores de Fármacos/química , Portadores de Fármacos/farmacología , Femenino , Humanos , Compuestos Orgánicos de Estaño/química , Compuestos Orgánicos de Estaño/farmacología , Neoplasias Ováricas/tratamiento farmacológico , Neoplasias Ováricas/metabolismo , Neoplasias Ováricas/patología , Porosidad , Especies Reactivas de Oxígeno/metabolismo , Factor de Transcripción STAT3/metabolismo , Dióxido de Silicio/química , Dióxido de Silicio/farmacología , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
5.
Pharm Res ; 33(6): 1351-8, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-27033349

RESUMEN

PROPOSE: Tin complexes demonstrate antiproliferative activities in some case higher than cisplatin, with IC50 at the low micromolar range. We have previously showed that the cyclic trinuclear complex of Sn(IV) bearing an aromatic oximehydroxamic acid group [nBu2Sn(L)]3 (L=N,2-dihydroxy-5-[N-hydroxyethanimidoyl]benzamide) (MG85) shows high anti-proliferative activity, induces apoptosis and oxidative stress, and causes destabilization of tubulin microtubules, particularly in colorectal carcinoma cells. Despite the great efficacy towards cancer cells, this complex still shows some cytotoxicity to healthy cells. Targeted delivery of this complex specifically towards cancer cells might foster cancer treatment. METHODS: MG85 complex was encapsulated into liposomal formulation with and without an active targeting moiety and cancer and healthy cells cytotoxicity was evaluated. RESULTS: Encapsulation of MG85 complex in targeting PEGylated liposomes enhanced colorectal carcinoma (HCT116) cancer cell death when compared to free complex, whilst decreasing cytotoxicity in non-tumor cells. Labeling of liposomes with Rhodamine allowed assessing internalization in cells, which showed significant cell uptake after 6 h of incubation. Cetuximab was used as targeting moiety in the PEGylated liposomes that displayed higher internalization rate in HCT116 cells when compared with non-targeted liposomes, which seems to internalize via active binding of Cetuximab to cells. CONCLUSIONS: The proposed formulation open new avenues in the design of innovative transition metal-based vectorization systems that may be further extended to other novel metal complexes towards the improvement of their anti-cancer efficacy, which is usually hampered by solubility issues and/or toxicity to healthy tissues.


Asunto(s)
Antineoplásicos/administración & dosificación , Neoplasias Colorrectales/tratamiento farmacológico , Sistemas de Liberación de Medicamentos/métodos , Lípidos/química , Neoplasias Hepáticas/tratamiento farmacológico , Compuestos Orgánicos de Estaño/administración & dosificación , Polietilenglicoles/química , Antineoplásicos/química , Antineoplásicos/metabolismo , Antineoplásicos/toxicidad , Transporte Biológico , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Cetuximab/administración & dosificación , Cetuximab/química , Cetuximab/metabolismo , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/patología , Relación Dosis-Respuesta a Droga , Composición de Medicamentos , Células HCT116 , Células Hep G2 , Humanos , Concentración 50 Inhibidora , Cinética , Liposomas , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patología , Compuestos Orgánicos de Estaño/química , Compuestos Orgánicos de Estaño/metabolismo , Compuestos Orgánicos de Estaño/toxicidad
6.
J Inorg Biochem ; 133: 1-7, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24413257

RESUMEN

Four diorganotin(IV) derivatives, dibutylbis[4-chloro-N-(hydroxy-<κ>O)benzamidato-<κ>O]tin(IV) (DBDCT), dibutylbis[2,6-difluoro-N-(hydroxy-<κ>O)benzamidato-<κ>O]tin(IV) (DBDFT), bis[2,4-difluoro-N-(hydroxy-<κ>O)benzamidato-<κ>O]diphenyltin(IV) (DPDFT), and bis[2,4-dichloro-N-(hydroxy-<κ>O)benzamidato-<κ>O]diphenyltin(IV) (DPDCT), were compared for their antitumor activity in vitro and in vivo along with their cytotoxic selectivity against human normal cells and cancer cells. The in vitro cytotoxic activities against seven human cancer cell lines including Hep G2, SHSY5Y, HEC-1-B, EC, T24, HeLa and A549 along with human liver HL-7702, a human normal hepatocytes cell, were observed by the MTT assay. The cytotoxic selectivity of the four compounds was compared by using HL-7702 and Hep G2. The in vivo antitumor tests towards the sarcoma carcinoma S180 and hepatocellular carcinoma H22 on mice were carried out via injection intraperitoneally with cisplatin as the positive contrast drug. The results showed that, among the four compounds, DBDCT displayed the strongest cytotoxicity against the seven cancer cell lines. DPDCT had the highest antitumor activity in vivo. However, both of them had no cytotoxic selectivity against the human hepatocellular carcinoma HepG2 cells and normal liver HL-7702 cells. DPDFT had the most significant cytotoxic selectivity against HepG2 and displayed significantly antitumor activity in vitro and in vivo. In conclusion, DPDFT could act as a promising lead compound for the further structure optimization owing to its relatively low toxicity to human normal cell and potent antitumor activity against cancer cells.


Asunto(s)
Antineoplásicos/administración & dosificación , Benzamidas/administración & dosificación , Ensayos de Selección de Medicamentos Antitumorales , Neoplasias/tratamiento farmacológico , Animales , Antineoplásicos/química , Benzamidas/química , Cisplatino/administración & dosificación , Células HeLa , Células Hep G2 , Humanos , Ratones , Neoplasias/patología , Compuestos Orgánicos de Estaño/administración & dosificación
7.
Toxicology ; 276(3): 198-205, 2010 Oct 29.
Artículo en Inglés | MEDLINE | ID: mdl-20708649

RESUMEN

Triphenyltin (TPT) is an organotin compound (OTC) previously widely used as an antifouling agent in paints applied in the marine environment, a fungicide, and as an agricultural pesticide. In female aquatic invertebrates, certain OTCs induce the so-called imposex, an abnormal induction of male sex characteristics. OTC-induced environmental endocrine disruption also occurs in fish and mammals and a number of in vivo and in vitro studies have argued that OTCs may act through inhibition of the aromatase enzyme. In vivo studies supporting the aromatase inhibition hypothesis in mammals are lacking. Recently, the causal relationship between inhibition of aromatase and imposex was questioned, suggesting aromatase independent mechanisms of action for this phenomenon. We conducted a comprehensive investigation to identify the most sensitive window of exposure to TPTCl and to examine the effects of pre- and postnatal exposure on postnatal development in rats. The results on brain and gonadal aromatase activity obtained from offspring of dams exposed to 2 mg TPTCl/kg bw are reported here. Female and male offspring rats were exposed to 2 mg TPTCl/kg bw/d in utero from gestation day 6 through lactation until weaning on PND 21, or from gestation day 6 until termination at adulthood. Male offspring were sacrificed from PND 58 and female offspring at first estrus after PND 58. Pre- and postnatal TPT exposure clearly affected brain and gonadal aromatase activity in a sex-dependent fashion. While brain aromatase activity was significantly increased on PND 21 and at adulthood in female offspring, male offspring exhibited a significant decrease in brain aromatase activity only at adulthood. Ovarian aromatase activity was unaffected at both time points investigated. In contrast, testicular aromatase activity was significantly increased in males on PND 21 and significantly decreased at adulthood independent from the duration of treatment. The results of the present study confirm our previously reported observations regarding sex-dependent differences in sexual development after TPT exposure with the male rat being more susceptible to disturbances through this endocrine active compound than the female. We conclude that TPT administered during the particularly vulnerable period of development can affect aromatase activity in rats.


Asunto(s)
Aromatasa/metabolismo , Disruptores Endocrinos/toxicidad , Compuestos Orgánicos de Estaño/toxicidad , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Efectos Tardíos de la Exposición Prenatal/enzimología , Caracteres Sexuales , Animales , Animales Recién Nacidos , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Disruptores Endocrinos/administración & dosificación , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Femenino , Gónadas/efectos de los fármacos , Gónadas/enzimología , Masculino , Compuestos Orgánicos de Estaño/administración & dosificación , Embarazo , Ratas , Ratas Wistar
8.
Pancreas ; 39(8): 1220-5, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20531238

RESUMEN

OBJECTIVE: The role of bradykinin (BK) receptors in activating and sensitizing peripheral nociceptors is well known. Recently, we showed that spinal dynorphin was pronociceptive through direct or indirect BK receptor activation. Here, we explored the potential role of BK receptors in pain associated with persistent pancreatitis in rats. METHODS: Experimental pancreatitis and abdominal hypersensitivity were induced by intravenous administrations of dibutyltin dichloride (DBTC). [des-Arg-Leu]BK (B1 antagonist) and HOE 140 (B2 antagonist) were given by intraperitoneal or intrathecal injection. Dynorphin antiserum was given intrathecally. Reverse transcription-polymerase chain reaction was used to detect spinal mRNA for BK receptors. RESULTS: Dibutyltin dichloride-induced pancreatitis upregulated B1 and B2 mRNA in the thoracic dorsal root ganglion and B2, but not B1, in the pancreas. No changes in spinal B1 or B2 mRNA were observed. Intraperitoneal or intrathecal administration of HOE 140 dose dependently abolished DBTC-induced abdominal hypersensitivity, whereas [des-Arg-Leu]BK was without effect by either route of administration. Antiserum to dynorphin (intrathecal) abolished DBTC-induced hypersensitivity. CONCLUSIONS: These results suggest that blockade of peripheral or spinal BK B2 receptors may be an effective approach for diminishing pain associated with pancreatitis. Moreover, it is suggested that spinal dynorphin may maintain pancreatitis pain through direct or indirect activation of BK B2 receptors in the spinal cord.


Asunto(s)
Antagonistas del Receptor de Bradiquinina B2 , Bradiquinina/análogos & derivados , Dolor/prevención & control , Pancreatitis/complicaciones , Dolor Abdominal/inducido químicamente , Dolor Abdominal/prevención & control , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/farmacología , Bradiquinina/administración & dosificación , Bradiquinina/farmacología , Antagonistas del Receptor de Bradiquinina B1 , Dinorfinas/inmunología , Ganglios Espinales/efectos de los fármacos , Ganglios Espinales/metabolismo , Expresión Génica/efectos de los fármacos , Sueros Inmunes/administración & dosificación , Sueros Inmunes/inmunología , Sueros Inmunes/farmacología , Inyecciones Intraperitoneales , Inyecciones Intravenosas , Inyecciones Espinales , Masculino , Compuestos Orgánicos de Estaño/administración & dosificación , Compuestos Orgánicos de Estaño/toxicidad , Dolor/etiología , Dolor/fisiopatología , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Páncreas/patología , Pancreatitis/inducido químicamente , Ratas , Ratas Sprague-Dawley , Receptor de Bradiquinina B1/genética , Receptor de Bradiquinina B1/metabolismo , Receptor de Bradiquinina B2/genética , Receptor de Bradiquinina B2/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Médula Espinal/efectos de los fármacos , Médula Espinal/metabolismo
9.
J Immunotoxicol ; 6(3): 184-93, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19678761

RESUMEN

Organotin compounds are known to cause thymic atrophy and an accompanying deficiency of cell-mediated immunity. The study reported here focused on cell death in the thymus as a contributing factor in the induction of thymic atrophy following exposure to dibutyltin (DBTC) and tributyltin (TBTC). In an in vivo study, a reversible thymic atrophy was induced in rats by a single intraperitoneal administration (2.0 mg/kg) of DBTC or TBTC; the magnitude of this effect over a 4-d post-treatment period differed between the two agents. In in vitro studies, T-lymphocytes were isolated from thymuses of naïve rats and then exposed to 1 microM DBTC or TBTC for varying periods of time. Analysis by flow cytometry showed that DBTC induced primarily necrosis, while TBTC induced apoptosis, of the cells. Activities of caspase-8, -9, and -3 were also measured; TBTC exposure caused marked increases in the activities, while DBTC exposure did not cause any significant change. TBTC exposure also appeared to induce expression of CAD (which fragments DNA), but had minimal effect on levels of the CAD inhibitor, ICAD. In contrast, DBTC exposure resulted in a larger level of ICAD expression. WST-8 and JC-1 assays were used to evaluate mitochondrial function, since a strong activation of caspase-9 by TBTC suggested mitochondrial involvement. The involvement of caspase in the activation was examined using cytochrome c expression; cytochrome expression and the loss of mitochondrial function occurred within 10 min of TBTC exposure. DBTC exposure affected the mitochondria less. These results indicated that effects on mitochondria likely played an important role in the induction of apoptosis by TBTC. The results of this study show that DBTC and TBTC induce necrosis and apoptosis of T-lymphocytes, respectively, by apparently indicating different mechanisms of cell death. It follows that these increases in cell death induced by these organotin compounds likely contributed to the thymic atrophy observed in the rats here.


Asunto(s)
Mitocondrias/efectos de los fármacos , Compuestos Orgánicos de Estaño/administración & dosificación , Linfocitos T/efectos de los fármacos , Timo/efectos de los fármacos , Compuestos de Trialquiltina/administración & dosificación , Animales , Apoptosis/efectos de los fármacos , Apoptosis/inmunología , Proteínas Reguladoras de la Apoptosis/genética , Proteínas Reguladoras de la Apoptosis/inmunología , Proteínas Reguladoras de la Apoptosis/metabolismo , Caspasas/genética , Caspasas/metabolismo , Células Cultivadas , Desoxirribonucleasas/genética , Desoxirribonucleasas/inmunología , Desoxirribonucleasas/metabolismo , Activación Enzimática/efectos de los fármacos , Activación Enzimática/inmunología , Inyecciones Intraperitoneales , Masculino , Mitocondrias/inmunología , Mitocondrias/metabolismo , Necrosis/inmunología , Compuestos Orgánicos de Estaño/farmacología , Ratas , Ratas Wistar , Linfocitos T/inmunología , Linfocitos T/metabolismo , Linfocitos T/patología , Timo/inmunología , Timo/metabolismo , Timo/patología , Toxicogenética , Compuestos de Trialquiltina/farmacología
10.
Anal Sci ; 25(5): 699-703, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19430156

RESUMEN

Dibutyldi(4-chlorobenzohydroxamato)tin(IV) is a new diorganotin(IV) arylhydroxamate complex with 4-chloro-benzohydroxamic acid as ligand which shows high in vivo and in vitro antitumor activity. A high performance liquid chromatographic (HPLC) method using a Diamonsil ODS column was first validated in the pharmacokinetic studies in rat plasma. The plasma was deproteinized with methanol that contained acetanilide as the internal standard. The mobile phase was a mixture of methanol and 0.5% trifluoroacetic acid (TFA) in water (30:70) (pH 3.0). The detection wavelength was set at 238 nm. A linear curve over the concentration range 0.1-25 microg/ml (r = 0.9992) was obtained. The method was used to determine the concentration-time profiles for dibutyldi(4-chlorobenzohydroxamato)tin(IV) in the plasma after a single intravenous dose of 2, 5, and 12 mg/kg to rats. The pharmacokinetics parameter calculations and modeling were carried out using the 3p97 pharmacokinetics software. A nonlinear pharmacokinetics was found in rats at doses from 2 to 12 mg/kg. The results showed that the concentration-time curves of dibutyldi(4-chlorobenzohydroxamato)-tin(IV) in rat plasma could be fitted to two-compartment model.


Asunto(s)
Antineoplásicos/sangre , Antineoplásicos/farmacocinética , Análisis Químico de la Sangre/métodos , Cromatografía Líquida de Alta Presión/métodos , Compuestos Orgánicos de Estaño/sangre , Compuestos Orgánicos de Estaño/farmacocinética , Animales , Antineoplásicos/administración & dosificación , Femenino , Modelos Lineales , Masculino , Compuestos Orgánicos de Estaño/administración & dosificación , Ratas , Ratas Wistar , Sensibilidad y Especificidad , Factores de Tiempo
11.
Neurotoxicol Teratol ; 29(6): 622-33, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17764894

RESUMEN

Dimethyltin (DMT) is one of several organotins that are detected in domestic water supplies due to their use as plastic stabilizers for polyvinyl chloride (PVC) and chlorinated PVC (CPVC) products. A limited number of in vitro and in vivo studies suggest that DMT may produce developmental neurotoxicity; therefore, we initiated studies to evaluate long-term neurobehavioral changes in offspring following perinatal exposure. In the first study, female Sprague-Dawley rats were exposed via drinking water to DMT (0, 3, 15, 74 ppm) before mating and throughout gestation and lactation. Male offspring were tested for changes in: 1) preweaning learning in an associative runway task, 2) motor activity ontogeny, 3) spatial learning and retention in the Morris water maze as adults, 4) brain weight, 5) biochemical evidence of apoptosis, and 6) neuropathology. DMT toxicity was expressed as depressed maternal weight gain (74 ppm), and in the offspring, decreased brain weight (3, 74 ppm), decreased apoptosis (all concentrations), mild vacuolation in adult offspring (all concentrations), and slower learning in the water maze (15 ppm) due to altered spatial search patterns. In a second study, DMT exposure (same concentrations) occurred from gestational day 6 to weaning. Male and female offspring were tested. The high concentration again depressed maternal weight gain, decreased offspring birth weight and preweaning growth, and decreased brain weight. Increased and decreased apoptotic markers were measured, depending on age. Learning deficits were observed in the runway at postnatal day 11 (15, 74 ppm) and again in the adult offspring in the water maze (15 ppm). The results of both studies demonstrate a reproducible effect of 15 ppm perinatal DMT exposure on spatial learning. Changes in expression of apoptosis, brain weight, and the occurrence of neuropathological lesions also indicate potential neurotoxicity of DMT. These results were in contrast to earlier findings with monomethyl tin, for which only similar neuropathological lesions were observed. Thus, developmental neurotoxicity may be produced in offspring following gestational exposure to DMT in drinking water.


Asunto(s)
Estudios de Evaluación como Asunto , Síndromes de Neurotoxicidad/etiología , Síndromes de Neurotoxicidad/fisiopatología , Compuestos Orgánicos de Estaño/toxicidad , Efectos Tardíos de la Exposición Prenatal , Factores de Edad , Análisis de Varianza , Animales , Animales Recién Nacidos , Apoptosis/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Tronco Encefálico/patología , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Femenino , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Síndromes de Neurotoxicidad/patología , Compuestos Orgánicos de Estaño/administración & dosificación , Embarazo , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Abastecimiento de Agua
12.
Environ Toxicol ; 22(1): 44-52, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17295259

RESUMEN

In this study, we examined the adverse effects of dibutyltin on initiation and maintenance of pregnancy after maternal administration during early pregnancy in mice. Following successful mating, female ICR mice were given dibutyltin dichloride (DBTCl) at 0, 7.6, 15.2, or 30.4 mg/kg bw/day by gastric intubation on days 0-3 or days 4-7 of pregnancy. Female mice were sacrificed on day 18 of pregnancy, and the pregnancy outcome was determined. After administration of DBTCl on days 0-3, the rate of nonpregnant females and the incidence of preimplantation embryonic loss were significantly increased at 30.4 mg/kg bw/day. The incidences of postimplantation embryonic loss in females given DBTCl on days 0-3 at 15.2 mg/kg and higher and on days 4-7 at 7.6 mg/kg bw/day and higher were increased. No increase in the incidence of fetuses with external malformations was observed after the administration of DBTCl on days 0-3 or days 4-7. A decline in the serum progesterone levels was detected in mice given DBTCl at 30.4 mg/kg bw/day on days 0-3 or days 4-7 of pregnancy. The data show that DBTCl adversely affects the initiation and maintenance of pregnancy when administered during early pregnancy in mice and suggest that the decline in serum progesterone levels is responsible for pregnancy failure.


Asunto(s)
Pérdida del Embrión/inducido químicamente , Inmunosupresores/toxicidad , Compuestos Orgánicos de Estaño/toxicidad , Mantenimiento del Embarazo/efectos de los fármacos , Preñez/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Femenino , Ratones , Ratones Endogámicos ICR , Compuestos Orgánicos de Estaño/administración & dosificación , Embarazo , Primer Trimestre del Embarazo , Progesterona/sangre , Factores de Tiempo
13.
Food Addit Contam ; 23(8): 749-56, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16807202

RESUMEN

The objective of this study was to estimate the intake of organic tin compounds from foodstuffs in a Finnish market basket. The study was conducted by collecting 13 market baskets from supermarkets and market places in the city of Kuopio, eastern Finland. Altogether 115 different food items were bought. In each basket, foodstuffs were mixed in proportion to their consumption and analysed by GC/MS for seven organic tin compounds (mono-, di-, and tributyltin, mono-, di-, and triphenyltin, and dioctyltin). Organotin compounds were detected in only four baskets, with the fish basket containing the largest number of different organotins. The European Food Safety Authority has established a tolerable daily intake of 250 ng kg(-1) body weight for the sum of dibutyltin, tributyltin, triphenyltin and dioctyltin. According to this study, the daily intake of these compounds was 2.47 ng kg(-1) body weight, of which 81% originated from the fish basket. This exposure is only 1% of the tolerable daily intake and poses negligible risk to the average consumer. However, for consumers eating large quantities of fish from contaminated areas, the intake may be much higher.


Asunto(s)
Dieta , Contaminantes Ambientales/administración & dosificación , Contaminación de Alimentos/análisis , Compuestos Orgánicos de Estaño/administración & dosificación , Animales , Exposición a Riesgos Ambientales/efectos adversos , Finlandia , Peces , Cromatografía de Gases y Espectrometría de Masas/métodos , Humanos , Compuestos Orgánicos de Estaño/análisis
14.
Toxicol In Vitro ; 20(7): 1145-53, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16581225

RESUMEN

Organotin effects on the Na-dependent ATPases involved in ionic regulation of aquatic animals are poorly known, in spite of the largely documented contamination of seafood, especially bivalve molluscs. This study deals with the in vitro effect of TBT on the Na,K-ATPase and the ouabain-insensitive Na-ATPase in gill and mantle microsomes from the cultured bivalve molluscs Tapes philippinarum and Mytilus galloprovincialis. In the mussel also MBT, DBT and TeET were tested. While in both species the Na-ATPase showed an overall refractoriness to organotins, the Na,K-ATPase was progressively inhibited by increasing TBT concentrations (0-34 microM). In both species the Na,K-ATPase activity was more strongly inhibited in the gills than in the mantle. At the maximal TBT concentration tested (34.4 microM), while gill Na,K-ATPase activity was abolished, mantle enzyme activity was, respectively, reduced to 20% in T. philippinarum and to 50% in M. galloprovincialis. Mussel Na,K-ATPase was differently susceptive to the organotins tested and in both tissues showed an inhibition efficiency order TBT>DBT>>MBT=TeET (no effect), tentatively related to the different organotin polarity and to a possible interaction with membrane-bound enzyme complexes. The different response of the two ATPases to organotins is consistent with the known different susceptivity of the two enzyme activities to environmental contaminants, assay conditions and endogenous factors.


Asunto(s)
Bivalvos/enzimología , Compuestos Orgánicos de Estaño/toxicidad , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Compuestos de Trialquiltina/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Branquias/enzimología , Modelos Lineales , Microsomas/enzimología , Mytilus/enzimología , Compuestos Orgánicos de Estaño/administración & dosificación , Compuestos Orgánicos de Estaño/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Especificidad de la Especie , Compuestos de Trialquiltina/administración & dosificación , Compuestos de Trialquiltina/metabolismo
15.
Neurotoxicology ; 27(3): 409-20, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16442161

RESUMEN

Organotins such as monomethyltin (MMT) are widely used as heat stabilizers in PVC and CPVC piping, which results in their presence in drinking water supplies. Concern for neurotoxicity produced by organotin exposure during development has been raised by published findings of a deficit on a runway learning task in rat pups perinatally exposed to MMT (Noland EA, Taylor DH, Bull RJ. Monomethyl and trimethyltin compounds induce learning deficiencies in young rats. Neurobehav Toxicol Teratol 1982;4:539-44). The objective of these studies was to replicate the earlier publication and further define the dose-response characteristics of MMT following perinatal exposure. In Experiment 1, female Sprague-Dawley rats were exposed via drinking water to MMT (0, 10, 50, 245 ppm) before mating and throughout gestation and lactation (until weaning at postnatal day [PND] 21). Behavioral assessments of the offspring included: a runway test (PND 11) in which the rat pups learned to negotiate a runway for dry suckling reward; motor activity habituation (PNDs 13, 17, and 21); learning in the Morris water maze (as adults). Other endpoints in the offspring included measures of apoptosis (DNA fragmentation) at PND 22 and as adults, as well as brain weights and neuropathological evaluation at PND 2, 12, 22, and as adults. There were no effects on any measure of growth, development, cognitive function, or apoptosis following MMT exposure. There was a trend towards decreased brain weight in the high dose group. In addition, there was vacuolation of the neuropil in a focal area of the cerebral cortex of the adult offspring in all MMT dose groups (1-3 rats per treatment group). In Experiment 2, pregnant rats were exposed from gestational day 6 until weaning to 500 ppm MMT in drinking water. The offspring behavioral assessments again included the runway task (PND 11), motor activity habituation (PND 17), and Morris water maze (as adults). In this second study, MMT-exposed females consumed significantly less water than the controls throughout both gestation and lactation, although neither dam nor pup weights were affected. As in Experiment 1, MMT-exposure did not alter pup runway performance, motor activity, or cognitive function. These results indicate that perinatal exposure to MMT, even at concentrations which decrease fluid intake, does not result in significant neurobehavioral or cognitive deficits. While mild neuropathological lesions were observed in the adult offspring, the biological significance of this restricted finding is unclear.


Asunto(s)
Síndromes de Neurotoxicidad/etiología , Síndromes de Neurotoxicidad/fisiopatología , Compuestos Orgánicos de Estaño/toxicidad , Efectos Tardíos de la Exposición Prenatal , Animales , Animales Recién Nacidos , Apoptosis/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Encéfalo/crecimiento & desarrollo , Encéfalo/patología , Fragmentación del ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Síndromes de Neurotoxicidad/patología , Compuestos Orgánicos de Estaño/administración & dosificación , Embarazo , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos , Agua/administración & dosificación
16.
Ecotoxicol Environ Saf ; 64(2): 155-62, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16406593

RESUMEN

Specimens of Bolinus brandaris (neogastropod) were injected with a single dose of 500 ng/g body weight (b.w.) of tributyltin chloride (TBTCl) or triphenyltin chloride (TPTCl), or a mixture of both compounds (250 ng TBT/g b.w.+250 ng TPT/g b.w.), for a period of up to 31 days. At the end of 4 weeks, significant increases in the female penis size of those gastropods injected with TBT (P<0.05), TPT (P<0.05), or the mixture TBT+TPT (P<0.01) were recorded. In parallel, a group of animals was injected with the neuropeptide APGWamide but this compound failed to promote imposex, suggesting that APGWamide is not involved in imposex promotion in B. brandaris. Acetylcholinesterase activity, a biomarker of neurotoxicity, was determined in the neuroganglia at the end of the experiment, but no significant differences among treatments were found. Overall, these results support the hypothesis that TPT also acts as an endocrine disrupter in this neogastropod species. Our observations also highlight, for the first time, synergistic effects of organotin mixtures having imposex promotion as an endpoint.


Asunto(s)
Antiinfecciosos/toxicidad , Trastornos del Desarrollo Sexual/inducido químicamente , Gastrópodos/efectos de los fármacos , Compuestos Orgánicos de Estaño/toxicidad , Compuestos de Trialquiltina/toxicidad , Contaminantes del Agua/toxicidad , Animales , Antiinfecciosos/administración & dosificación , Sinergismo Farmacológico , Femenino , Masculino , Compuestos Orgánicos de Estaño/administración & dosificación , Compuestos de Trialquiltina/administración & dosificación , Contaminantes del Agua/administración & dosificación
17.
J Inorg Biochem ; 100(2): 206-13, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16384601

RESUMEN

The two Sn(IV) complexes synthesized using calix[4]arene-1,3-di-acid derivative were characterized by analytical, (1)H, (13)C and (119)Sn NMR, matrix assisted laser desorption ionization mass, and (119)Sn Mossbauer techniques and found that the complexes are tetranuclear possessing structurally two different types of tin centers. These complexes were evaluated for their protective value against blood and tissue oxidative stress in lead exposed male albino rats of Wistar strain. The results suggest that the two tin complexes significantly protect changes in lead induced biochemical variables indicative of heme synthesis pathway and exhibit only moderate effect on tissue oxidative stress. The beneficial effects could be attributed mainly to the ability of Sn(IV) complexes in preventing absorption of lead to the target sites/tissues.


Asunto(s)
Calixarenos/química , Plomo/toxicidad , Compuestos Orgánicos de Estaño/química , Estaño/química , Animales , Plaquetas/citología , Calixarenos/administración & dosificación , Plomo/sangre , Espectroscopía de Resonancia Magnética , Masculino , Compuestos Orgánicos de Estaño/administración & dosificación , Compuestos Orgánicos de Estaño/síntesis química , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Espectroscopía Infrarroja por Transformada de Fourier , Espectroscopía de Mossbauer , Estaño/administración & dosificación , Estaño/sangre
18.
Acta Trop ; 95(1): 1-8, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15896700

RESUMEN

Visceral leishmaniasis is a life-threatening human disease commonly known as kala-azar. Leishmania donovani is the causative agent of this parasitic disease transmitted by the sand fly vector to infect hosts. Triphenyl tin salicylanilide thiosemicarbazone [Ph(3)Sn(OSal.TSCZH)] (TTST) which is an organometallic complex of triphenyl tin has been evaluated to explore possibility to develop a potent chemotherapeutic agent against visceral leishmaniasis. Effect of triphenyl tin complex on growth inhibition and host--parasite interaction were examined both in vitro and in vivo. Release of toxic superoxide radical was measured spectrophotometrically through the formation of blue formazan derived from reduced nitrobluetetrazolium. To understand mode of action of Ph(3)Sn(OSal.TSCZH), superoxide dismutase activity was determined spectrophotometrically by measuring ability of this enzyme to inhibit pyrogallol autoxidation and also by activity staining of the non-denaturing polyacrylamide gels after separating superoxide dismutase. Antileishmanial activity of triphenyl tin complex were found to be effective both in vitro and in vivo at lower concentrations compared to the existing toxic drugs available. IC(50) of Ph(3)Sn(OSal.TSCZH) was calculated as 0.05+/-0.01mg/L. Intracellular survival of the parasite in host macrophages was inhibited by TTST in a dose dependent manner. Parasite burden in spleen was reduced to 87% under TTST treatment (10mg/kg body weight) and under sodium antimony gluconate (20mg/kg body weight) reduced nearly to 65%. Its action as a chemotherapeutic agent is found to be mediated through inhibition of superoxide dismutase and simultaneous release of toxic superoxide radical. We propose that Ph(3) Sn(OSal.TSCZH) may be considered as a prospective candidate to establish a better line of therapeutic process against experimental visceral leishmaniasis.


Asunto(s)
Antiprotozoarios/farmacología , Leishmania donovani/efectos de los fármacos , Leishmaniasis Visceral/tratamiento farmacológico , Compuestos Orgánicos de Estaño/farmacología , Animales , Antiprotozoarios/administración & dosificación , Antiprotozoarios/uso terapéutico , Cricetinae , Interacciones Huésped-Parásitos , Humanos , Leishmania donovani/crecimiento & desarrollo , Leishmaniasis Visceral/parasitología , Macrófagos Peritoneales/parasitología , Mesocricetus , Compuestos Orgánicos de Estaño/administración & dosificación , Compuestos Orgánicos de Estaño/química , Compuestos Orgánicos de Estaño/uso terapéutico , Pruebas de Sensibilidad Parasitaria , Bazo/parasitología , Superóxido Dismutasa/metabolismo
19.
Reprod Toxicol ; 17(4): 393-9, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12849849

RESUMEN

In our previous study, dibutyltin dichloride (DBTCl) caused preimplantation embryonic loss and postimplantation embryonic loss in rats following administration at 7.6 mg/kg and above on Days 0-3 and at 3.8 mg/kg and above on Days 4-7 of pregnancy, respectively. This study was designed to assess the effects of DBTCl on uterine function as a cause of early embryonic loss using pseudopregnant rats. DBTCl was given orally to pseudopregnant rats at 3.8, 7.6 or 15.2 mg/kg on pseudopregnant day (PPD) 0-3 or on PPD 4-7. The decidual cell response was induced by bilateral uterine scratch on PPD 4. The uterine weight on PPD 9 served as an index of uterine decidualization. Uterine weight and serum progesterone levels on PPD 9 were significantly decreased after administration of DBTCl at 7.6 mg/kg and above on PPD 0-3 and PPD 4-7. DBTCl had no effect on the serum estradiol levels and number of corpora lutea. Administration of progesterone reversed the suppression of uterine decidualization in rats given DBTCl on PPD 0-3. It can be concluded that DBTCl suppresses the uterine decidual cell response and decreases progesterone levels, and these effects are responsible for early embryonic loss due to DBTCl exposure.


Asunto(s)
Decidua/efectos de los fármacos , Pérdida del Embrión/etiología , Compuestos Orgánicos de Estaño/toxicidad , Animales , Peso Corporal/efectos de los fármacos , Decidua/patología , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Pérdida del Embrión/inducido químicamente , Femenino , Edad Gestacional , Intubación Gastrointestinal , Tamaño de los Órganos/efectos de los fármacos , Compuestos Orgánicos de Estaño/administración & dosificación , Progesterona/sangre , Seudoembarazo/sangre , Ratas , Ratas Wistar
20.
J Appl Toxicol ; 23(1): 31-5, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12518334

RESUMEN

The metabolism of tetraphenyltin in rat liver and kidney has been examined. Tetraphenyltin and its metabolites in the tissue were determined periodically for 96 h after a single oral dose of 55.4 mg kg(-1) of tetraphenyltin by gas chromatography. The gas chromatographic method was able to determine simultaneously both inorganic tin and phenyltin compounds. Although initial (at 24 h) levels of tetraphenyltin in the liver approximated four times those in the kidneys, the levels of tetraphenyltin decreased more rapidly with time than those in the kidneys. These findings show that the tetraphenyltin accumulated more rapidly and highly in the liver, but was metabolized faster than that in the kidney. The levels of total tin in the liver 24 h after treatment were distinctly lower than those of di- or triphenyltin treatments in our previous studies and none of the animals showed characteristic symptoms. The toxic potencies of organotins generally correlate with accumulation of the chemicals. These results imply that the slight toxicities of tetraphenyltin might be due to the relatively low uptake of tin compounds after ingestion. The highest tin concentration among the metabolites of tetraphenyltin in the tissue, especially in liver, was observed as diphenyltin throughout the time period studied. These results suggest that part of the administered tetraphenyltin may cause some harmful effects as diphenyltin in rats, and this must be taken into consideration in toxicological research on tetraphenyltin.


Asunto(s)
Compuestos Orgánicos de Estaño/farmacocinética , Administración Oral , Animales , Cromatografía de Gases , Riñón/metabolismo , Hígado/metabolismo , Masculino , Compuestos Orgánicos de Estaño/administración & dosificación , Compuestos Orgánicos de Estaño/análisis , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA